KalVista Pharmaceuticals (KALV) Property, Plant & Equipment (Net) (QoQ) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | KalVista Pharmaceuticals | 1.44 Bn | 1.25 Bn | 56.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 31, 2025 | 3.97% |
| Oct 31, 2024 | -2.90% |
| Jul 31, 2024 | -5.70% |
| Apr 30, 2024 | -8.09% |
| Jan 31, 2024 | -3.16% |
| Oct 31, 2023 | -11.06% |
| Jul 31, 2023 | -4.58% |
| Apr 30, 2023 | -2.93% |
| Jan 31, 2023 | -0.75% |
| Oct 31, 2022 | 0.99% |
| Jul 31, 2022 | 39.12% |
| Apr 30, 2022 | -1.67% |
| Jan 31, 2022 | 1.61% |
| Oct 31, 2021 | 12.14% |
| Jul 31, 2021 | 8.54% |
| Apr 30, 2021 | -4.12% |
| Jan 31, 2021 | -1.11% |
| Oct 31, 2020 | -6.44% |
| Jul 31, 2020 | -1.17% |
| Apr 30, 2020 | -9.60% |
| Jan 31, 2020 | -4.44% |
| Oct 31, 2019 | 4.88% |
| Jul 31, 2019 | -6.55% |
| Apr 30, 2019 | 5.42% |
| Jan 31, 2019 | -1.17% |
| Oct 31, 2018 | 2.48% |
| Jul 31, 2018 | 23.09% |
| Apr 30, 2018 | 137.21% |
| Jan 31, 2018 | 28.57% |
| Oct 31, 2017 | 1.69% |
| Jul 31, 2017 | 510.31% |
| Apr 30, 2017 | 0.00% |
| Mar 31, 2016 | -80.12% |
| Dec 31, 2015 | 122.38% |
| Sep 30, 2015 | -3.21% |
| Jun 30, 2015 | 13.68% |
| Mar 31, 2015 | 82.78% |